Home
About
Overview
Sharing Data
ORCID
Help
History (50)
Laparoscopy
Pharmaceutical Preparations
Arrestins
Antimicrobial Peptides Derived from the Immune Defense Protein CAP37 Inhibit TLR4 Activation by S100A9.
Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.
See All 50 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.
Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer. Mol Cancer Ther. 2018 10; 17(10):2136-2143.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Animals
Antineoplastic Agents
Apoptosis
Caspases
Cell Line, Tumor
Cell Movement
Cell Survival
Disease Models, Animal
Endometrial Neoplasms
Female
Humans
Immunohistochemistry
Middle Aged
Neoplasm Grading
Neoplasm Staging
Polycomb Repressive Complex 1
Xenograft Model Antitumor Assays
authors with profiles
Kai Ding
Priyabrata Mukherjee
Resham Bhattacharya
Shailendra Kumar Dhar Dwivedi